246 related articles for article (PubMed ID: 26685718)
1. Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial.
Zaher H; Rasheed H; El-Komy MM; Hegazy RA; Gawdat HI; Abdel Halim DM; Abdel Hay RM; Hegazy RA; Mohy AM
J Am Acad Dermatol; 2016 Mar; 74(3):499-505. PubMed ID: 26685718
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma.
Sulzberger L; Baillie R; Itinteang T; de Jong S; Marsh R; Leadbitter P; Tan ST
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):381-6. PubMed ID: 26612192
[TBL] [Abstract][Full Text] [Related]
3. Treatment of infantile haemangioma with captopril.
Tan ST; Itinteang T; Day DJ; O'Donnell C; Mathy JA; Leadbitter P
Br J Dermatol; 2012 Sep; 167(3):619-24. PubMed ID: 22533490
[TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on infantile haemangiomas: a retrospective case series.
Christou EM; Wargon O
Australas J Dermatol; 2012 Aug; 53(3):216-8. PubMed ID: 22671578
[TBL] [Abstract][Full Text] [Related]
5. β-blocker therapy for infantile hemangioma.
Koh SP; Leadbitter P; Smithers F; Tan ST
Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682
[TBL] [Abstract][Full Text] [Related]
6. The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment.
Dornhoffer JR; Wei T; Zhang H; Miller E; A Cleves M; Richter GT
Pediatr Res; 2017 Jul; 82(1):155-163. PubMed ID: 28376078
[TBL] [Abstract][Full Text] [Related]
7. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
8. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
12. The role of propranolol in the treatment of infantile hemangioma.
Laranjo S; Costa G; Paramés F; Freitas I; Martins JD; Trigo C; Pinto FF
Rev Port Cardiol; 2014 May; 33(5):289-95. PubMed ID: 24906291
[TBL] [Abstract][Full Text] [Related]
13. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
[TBL] [Abstract][Full Text] [Related]
14. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.
Tan ST; Itinteang T; Leadbitter P
Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335
[TBL] [Abstract][Full Text] [Related]
15. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment.
Przewratil P; Kobos J; Wnęk A; Szemraj J; Wyrzykowski D; Chrzanowska B; Andrzejewska E; Taran K
Immunol Lett; 2016 Jul; 175():44-9. PubMed ID: 27178307
[TBL] [Abstract][Full Text] [Related]
16. Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age.
Moyakine AV; Spillekom-van Koulil S; van der Vleuten CJM
J Am Acad Dermatol; 2017 Jul; 77(1):105-108. PubMed ID: 28190620
[TBL] [Abstract][Full Text] [Related]
17. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol.
Rotter A; de Oliveira ZNP
J Dtsch Dermatol Ges; 2017 Dec; 15(12):1185-1190. PubMed ID: 29193649
[TBL] [Abstract][Full Text] [Related]
18. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
19. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser.
Reddy KK; Blei F; Brauer JA; Waner M; Anolik R; Bernstein L; Brightman L; Hale E; Karen J; Weiss E; Geronemus RG
Dermatol Surg; 2013 Jun; 39(6):923-33. PubMed ID: 23458381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]